Diabetes Mellitus Clinical Trial
Official title:
Videolaryngoscopy Versus Direct Laryngoscopy for Tracheal Intubation in Patients With Diabetes Mellitus
The use of videolarygoscopy (VL) as first choice for tracheal intubation versus direct
laryngoscopy (DL) is a matter of debate.
These two methods were compared in several studies. Videolaryngoscopes may reduce the number
of failed intubations, particularly among patients presenting with a difficult airway. They
improve the glottic view and may reduce airway trauma. DM is accepted as a risk factor for
difficult intubation.
The aim of this study is to compare VL to DL in adult patients requiring tracheal intubation
for anesthesia, in terms of intubation success, glottic view quality, intubation failure,
intubation time, conversion to another laringoscopy method and adverse outcomes related to
tracheal intubation.
The use of videolarygoscopy (VL) as first choice for tracheal intubation versus direct
laryngoscopy (DL) is a matter of debate.
These two methods were compared in several studies. First attempt intubation success and
glottic visualization with VL versus DL by pediatric emergency medicine providers in
simulated patients were evaluated and it was concluded that VL was associated with greater
first-attempt success during intubation by pediatric emergency physicians on an adult
simulator.
The ease of viewing the glottis under direct vision during conventional laryngoscopy with the
quality of indirectly viewing on a monitor during laryngoscopy with a Macintosh
videolaryngoscope was compared in a multicenter study. The results were that VL can lead to
better viewing conditions but in rare cases it may result in worse viewing conditions.
The study evaluating the efficacy and safety of VL compared to DL in decreasing the time and
attempts required and increasing the success rate for endotracheal intubation in neonates
concluded that there was insufficient evidence to recommend or refute the use of VL for
endotracheal intubation in neonates.
Diverse videolaryngoscopes where also compared in patients undergoing tracheal intubation for
elective surgery: the GlideScope Ranger (GlideScope, Bothell, WA), the V-MAC Storz Berci DCI
(Karl Storz, Tuttlingen, Germany), and the McGrath (McGrath series 5, Aircraft medical,
Edinburgh, UK) and tested whether it is feasible to intubate the trachea of patients with
indirect videolaryngoscopy without using a stylet. The authors concluded that the trachea of
a large proportion of patients with normal airways can be intubated successfully with certain
VL blades without using a stylet, although the three studied VL's clearly differ in outcome.
The Storz VL displaces soft tissues in the fashion of a classic Macintosh scope, affording
room for tracheal tube insertion and limiting the need for stylet use compared with the other
two scopes. Although VL's offer several advantages, including better visualization of the
glottic entrance and intubation conditions, a good laryngeal view does not guarantee easy or
successful tracheal tube insertion.
Three different videolarygoscope devices were compared to direct laringoscopy in obese
patients undergoing bariatric surgery: Video Mac and GlideScope required fewer intubation
attempts that DL and Video Mac provide shorter intubation times and improved glottis view
compared to DL.
A recent metanalysis stated that videolaryngoscopes may reduce the number of failed
intubations, particularly among patients presenting with a difficult airway. They improve the
glottic view and may reduce laryngeal/airway trauma. However currently, no evidence indicates
that use of a VLS reduces the number of intubation attempts or the incidence of hypoxia or
respiratory complications, and no evidence indicates that use of a VL's affects time required
for intubation.
DM is accepted as a risk factor for difficult intubation. The aim of this study is to compare
VL to DL in adult diabetic patients requiring tracheal intubation for anesthesia, in terms of
intubation success, glottic view quality, intubation failure, intubation time, conversion to
another laringoscopy method and adverse outcomes related to tracheal intubation.
METHODS After obtaining ethical approval and written informed patient consent, consecutive
patients having diabetes mellitus (DM) and requiring elective intubation for anesthesia will
be randomly allocated to either the videolaryngoscopy (McGRATH MAC videolaryngoscope) (Group
VL) or the direct larngoscopy (Macintosh laryngoscope) (Group DL). Age, gender, body mass
index, American Society of Anesthesiologists (ASA) physiologic classification, the duration
of DM will be recorded. The patients will be evaluated for difficult airway predictors and
the following parameters will be recorded: Malampati class, thyromental distance,
sternomental distance, mandibulohyoid distance, interincisor distance, neck circumference,
the ability of upper lip overbite and lower lip overbite, the presence of limited neck
extension. Fentanyl-propofol-rocuronium will be used for anesthesia induction. After
subsequent positive-pressure ventilation using a face mask and an oxygen-air-sevoflurane
mixture for 3 min, the trachea will be intubated according to group allocation using either
DL or VL. During intubation, the following data will be documented: intubation time, number
of intubation attempts, use of extra tools to facilitate intubation, conversion to another
laryngoscopy method,intubation difficulty score and the quality of the view of the glottis
will be assessed according to the Cormack and Lehane scoring system and the percentage of
glottic opening. Adverse events related to tracheal intubation will be also evaluated:
desaturation (SPO2<94), hypercabia (ETCO2>35), hypertension (mean arterial pressure >20%
above baseline values), tachycardia (heart rate >20% above baseline values), new onset
arrhythmia, laryngospasm, bronchospasm, airway trauma and sore throat in PACU).
The primary outcome measure is the first-attempt intubation success; intubation timeand ease
of intubation, secondary outcome measures are the glottic view guality, conversion to another
laryngoscopy method and adverse outcomes related to tracheal intubation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |